Annual D&A
$3.44 M
+$1.63 M+90.25%
December 31, 2023
Summary
- As of February 20, 2025, CUE annual depreciation & amortization is $3.44 million, with the most recent change of +$1.63 million (+90.25%) on December 31, 2023.
- During the last 3 years, CUE annual D&A has risen by +$6.58 million (+209.25%).
- CUE annual D&A is now at all-time high.
Performance
CUE Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$877.00 K
+$15.00 K+1.74%
September 30, 2024
Summary
- As of February 20, 2025, CUE quarterly depreciation & amortization is $877.00 thousand, with the most recent change of +$15.00 thousand (+1.74%) on September 30, 2024.
- Over the past year, CUE quarterly D&A has increased by +$15.00 thousand (+1.74%).
- CUE quarterly D&A is now -65.82% below its all-time high of $2.57 million, reached on June 30, 2021.
Performance
CUE Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$3.44 M
+$21.00 K+0.61%
September 30, 2024
Summary
- As of February 20, 2025, CUE TTM depreciation & amortization is $3.44 million, with the most recent change of +$21.00 thousand (+0.61%) on September 30, 2024.
- Over the past year, CUE TTM D&A has increased by +$21.00 thousand (+0.61%).
- CUE TTM D&A is now at all-time high.
Performance
CUE TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
CUE Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +90.3% | +1.7% | +0.6% |
| 3 y3 years | +209.3% | +51.2% | +90.4% |
| 5 y5 years | +352.1% | +51.2% | +90.4% |
CUE Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +293.3% | -0.3% | +114.3% | at high | +170.1% |
| 5 y | 5-year | at high | +209.3% | -65.8% | +114.3% | at high | +170.1% |
| alltime | all time | at high | +209.3% | -65.8% | +114.3% | at high | +170.1% |
Cue Biopharma Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $877.00 K(+1.7%) | $3.44 M(+0.6%) |
| Jun 2024 | - | $862.00 K(+1.5%) | $3.42 M(+0.4%) |
| Mar 2024 | - | $849.00 K(-0.2%) | $3.40 M(-0.9%) |
| Dec 2023 | $3.44 M(+90.3%) | $851.00 K(-0.6%) | $3.44 M(+8.6%) |
| Sep 2023 | - | $856.00 K(+0.8%) | $3.17 M(+11.1%) |
| Jun 2023 | - | $849.00 K(-3.5%) | $2.85 M(+15.9%) |
| Mar 2023 | - | $880.00 K(+51.7%) | $2.46 M(+36.0%) |
| Dec 2022 | $1.81 M(-201.6%) | $580.00 K(+7.6%) | $1.81 M(-136.8%) |
| Sep 2022 | - | $539.00 K(+17.7%) | -$4.91 M(+23.4%) |
| Jun 2022 | - | $458.00 K(+100.0%) | -$3.98 M(+112.9%) |
| Mar 2022 | - | $229.00 K(-103.7%) | -$1.87 M(+5.0%) |
| Dec 2021 | -$1.78 M(-43.5%) | -$6.13 M(-517.4%) | -$1.78 M(-540.1%) |
| Sep 2021 | - | $1.47 M(-42.8%) | $404.00 K(-150.8%) |
| Jun 2021 | - | $2.57 M(+706.9%) | -$796.00 K(-74.2%) |
| Mar 2021 | - | $318.00 K(-108.1%) | -$3.09 M(-1.7%) |
| Dec 2020 | -$3.15 M | -$3.95 M(-1568.0%) | -$3.15 M(-411.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2020 | - | $269.00 K(-1.1%) | $1.01 M(+7.9%) |
| Jun 2020 | - | $272.00 K(+3.4%) | $935.80 K(-807.9%) |
| Mar 2020 | - | $263.00 K(+27.8%) | -$132.20 K(-116.3%) |
| Dec 2019 | $810.80 K(+6.7%) | $205.80 K(+5.5%) | $810.80 K(+0.2%) |
| Sep 2019 | - | $195.00 K(-124.5%) | $809.00 K(+0.1%) |
| Jun 2019 | - | -$796.00 K(-166.0%) | $808.00 K(-55.1%) |
| Mar 2019 | - | $1.21 M(+491.2%) | $1.80 M(+136.7%) |
| Dec 2018 | $760.00 K(+81.1%) | $204.00 K(+5.2%) | $760.00 K(+11.3%) |
| Sep 2018 | - | $194.00 K(-0.5%) | $682.60 K(+11.4%) |
| Jun 2018 | - | $195.00 K(+16.8%) | $612.60 K(+17.9%) |
| Mar 2018 | - | $167.00 K(+31.9%) | $519.60 K(+23.8%) |
| Dec 2017 | $419.60 K(+107.6%) | $126.60 K(+2.1%) | $419.60 K(+43.2%) |
| Sep 2017 | - | $124.00 K(+21.6%) | $293.00 K(+73.4%) |
| Jun 2017 | - | $102.00 K(+52.2%) | $169.00 K(+152.2%) |
| Mar 2017 | - | $67.00 K | $67.00 K |
| Dec 2016 | $202.10 K(+351.1%) | - | - |
| Dec 2015 | $44.80 K | - | - |
FAQ
- What is Cue Biopharma annual depreciation & amortization?
- What is the all time high annual D&A for Cue Biopharma?
- What is Cue Biopharma annual D&A year-on-year change?
- What is Cue Biopharma quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Cue Biopharma?
- What is Cue Biopharma quarterly D&A year-on-year change?
- What is Cue Biopharma TTM depreciation & amortization?
- What is the all time high TTM D&A for Cue Biopharma?
- What is Cue Biopharma TTM D&A year-on-year change?
What is Cue Biopharma annual depreciation & amortization?
The current annual D&A of CUE is $3.44 M
What is the all time high annual D&A for Cue Biopharma?
Cue Biopharma all-time high annual depreciation & amortization is $3.44 M
What is Cue Biopharma annual D&A year-on-year change?
Over the past year, CUE annual depreciation & amortization has changed by +$1.63 M (+90.25%)
What is Cue Biopharma quarterly depreciation & amortization?
The current quarterly D&A of CUE is $877.00 K
What is the all time high quarterly D&A for Cue Biopharma?
Cue Biopharma all-time high quarterly depreciation & amortization is $2.57 M
What is Cue Biopharma quarterly D&A year-on-year change?
Over the past year, CUE quarterly depreciation & amortization has changed by +$15.00 K (+1.74%)
What is Cue Biopharma TTM depreciation & amortization?
The current TTM D&A of CUE is $3.44 M
What is the all time high TTM D&A for Cue Biopharma?
Cue Biopharma all-time high TTM depreciation & amortization is $3.44 M
What is Cue Biopharma TTM D&A year-on-year change?
Over the past year, CUE TTM depreciation & amortization has changed by +$21.00 K (+0.61%)